346 related articles for article (PubMed ID: 26934358)
1. Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.
Huang T; Poole EM; Eliassen AH; Okereke OI; Kubzansky LD; Sood AK; Forman JP; Tworoger SS
Int J Cancer; 2016 Jul; 139(2):291-9. PubMed ID: 26934358
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive medication use and ovarian cancer survival.
Huang T; Townsend MK; Dood RL; Sood AK; Tworoger SS
Gynecol Oncol; 2021 Nov; 163(2):342-347. PubMed ID: 34556331
[TBL] [Abstract][Full Text] [Related]
3. Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer.
Harding BN; Delaney JA; Urban RR; Weiss NS
Gynecol Oncol; 2019 Aug; 154(2):426-431. PubMed ID: 31178150
[TBL] [Abstract][Full Text] [Related]
4. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
[TBL] [Abstract][Full Text] [Related]
5. Beta-blockers for hypertension.
Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
[TBL] [Abstract][Full Text] [Related]
6. Migraine and invasive epithelial ovarian cancer risk in the Nurses' Health Study II and the Women's Health Study.
Rice MS; Rist PM; Winter AC; Kurth T; Tworoger SS
Int J Cancer; 2018 Feb; 142(3):534-539. PubMed ID: 28929486
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive medication use and incident breast cancer in women.
Devore EE; Kim S; Ramin CA; Wegrzyn LR; Massa J; Holmes MD; Michels KB; Tamimi RM; Forman JP; Schernhammer ES
Breast Cancer Res Treat; 2015 Feb; 150(1):219-29. PubMed ID: 25701121
[TBL] [Abstract][Full Text] [Related]
8. The uses and expenses of antihypertensive medications among hypertensive adults.
Park C; Wang G; Ng BP; Fang J; Durthaler JM; Ayala C
Res Social Adm Pharm; 2020 Feb; 16(2):183-189. PubMed ID: 31085142
[TBL] [Abstract][Full Text] [Related]
9. Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients.
Cho MA; Jeong SY; Sohn I; Kim MS; Kang JH; Paik ES; Lee YY; Choi CH
Cancer Res Treat; 2020 Apr; 52(2):645-654. PubMed ID: 32019281
[TBL] [Abstract][Full Text] [Related]
10. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
11. Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies.
Huang T; Poole EM; Okereke OI; Kubzansky LD; Eliassen AH; Sood AK; Wang M; Tworoger SS
Gynecol Oncol; 2015 Dec; 139(3):481-6. PubMed ID: 26449316
[TBL] [Abstract][Full Text] [Related]
12. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.
Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1603-1610. PubMed ID: 28807926
[No Abstract] [Full Text] [Related]
13. Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN).
Jackson EA; Ruppert K; Derby CA; Lian Y; Neal-Perry G; Habel LA; Tepper PG; Harlow SD; Solomon DH
J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28232324
[TBL] [Abstract][Full Text] [Related]
14. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of leisure-time physical activity and risk of incident epithelial ovarian cancer: Impact by menopausal status.
Huang T; Eliassen AH; Hankinson SE; Okereke OI; Kubzansky LD; Wang M; Poole EM; Chavarro JE; Tworoger SS
Int J Cancer; 2016 Feb; 138(4):843-52. PubMed ID: 26335147
[TBL] [Abstract][Full Text] [Related]
16. Combination antihypertensive therapy among patients with COPD.
Herrin MA; Feemster LC; Crothers K; Uman JE; Bryson CL; Au DH
Chest; 2013 May; 143(5):1312-1320. PubMed ID: 23287970
[TBL] [Abstract][Full Text] [Related]
17. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.
Barnard ME; Poole EM; Curhan GC; Eliassen AH; Rosner BA; Terry KL; Tworoger SS
JAMA Oncol; 2018 Dec; 4(12):1675-1682. PubMed ID: 30286239
[TBL] [Abstract][Full Text] [Related]
18. Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study.
Psaty BM; Savage PJ; Tell GS; Polak JF; Hirsch CH; Gardin JM; McDonald RH
JAMA; 1993 Oct; 270(15):1837-41. PubMed ID: 8105112
[TBL] [Abstract][Full Text] [Related]
19. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
20. Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study.
Zhang Y; Song M; Chan AT; Meyerhardt JA; Willett WC; Giovannucci EL
Br J Cancer; 2022 Nov; 127(11):1974-1982. PubMed ID: 36138074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]